KMT9-IN-1

KMT9-IN-1 (Compound 8) is a KMT9 inhibitor and the ethyl ester prodrug of compound 7b. KMT9-IN-1 releases the active form 7b via esterases in cells. KMT9-IN-1 targets KMT9 in cells and reduces H4K12me1 levels. KMT9-IN-1 has antitumor activity against colon cancer. KMT9-IN-1 can be used in the research of prostate cancer and hepatocellular carcinoma.

For research use only. We do not sell to patients.

  • CAS No.: 2625406-61-1
  • Formula: C36H47ClFN7O5
  • Molecular Weight:712.25
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Epigenetic Reader Domain Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00